Equatorial Guinea Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial
AbstractObjectivesThe primary objective is to determine the efficacy of a single dose of ivermectin, administered to low risk, non-severe COVID-19 patients in the first 48 hours after symptom onset to reduce the proportion of patients with detectable SARS-CoV-2 RNA by Polymerase Chain Reaction (PCR) test from nasopharyngeal swab at day 7 post-treatment.The secondary objectives are:To assess the efficacy of ivermectin to reduce the SARS-CoV-2 viral load in the nasopharyngeal swab at day 7 post treatment.To assess the efficacy of ivermectin to improve symptom progression in treated patients.To assess the proportion of seroco...
Source: Trials - June 7, 2020 Category: Research Source Type: clinical trials

Regimen Optimization Trial of PfSPZ Vaccine in Equatorial Guinea
Condition: Malaria Interventions: Biological: PfSPZ Vaccine; Other: Normal saline; Biological: PfSPZ Challenge (for CHMI) Sponsors: Sanaria Inc.; Ifakara Health Institute; Swiss Tropical & Public Health Institute; Government of Equatorial Guinea; Noble Oil Services; Marathon Oil Corporation; Atlantic Methanol Production Company; Equatorial Guinea (EG) liquefied natural gas (LNG) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2018 Category: Research Source Type: clinical trials

Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.
Condition: Malaria Interventions: Biological: PfSPZ Vaccine; Biological: PfSPZ Challenge (for CHMI); Other: Normal Saline; Biological: PfSPZ Challenge (for PfSPZ-CVac) Sponsors: Sanaria Inc.; Ifakara Health Institute; Swiss Tropical & Public Health Institute; Government of Equatorial Guinea; Marathon Oil Corporation; Noble Oil Services; La Paz Medical Center, Malabo, Equatorial Guinea Not yet recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2016 Category: Research Source Type: clinical trials